Development of intergenotypic chimeric replicons for broad-spectrum antiviral activity characterization of hepatitis C virus polymerase inhibitors

被引：0
|
作者：
Herlihy, Koleen [1 ]
机构：
[1] Pfizer PGRD, La Jolla Labs, La Jolla, CA USA
来源：
ANTIVIRAL RESEARCH | 2007年 / 74卷 / 03期
关键词：
D O I：
10.1016/j.antiviral.2007.01.086
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
78
引用
收藏
页码：A59 / A59
页数：1
相关论文
共 50 条
  • [1] Development of intergenotypic chimeric replicons for broad-spectrum antiviral activity determination of hepatitis C virus polymerase inhibitors
    Herlihy, Koleen
    Graham, Joanne
    Kumpf, Robert
    Duggal, Rohit
    Patrick, Amy
    Shi, Stephanie
    HEPATOLOGY, 2007, 46 (04) : 853A - 853A
  • [2] Development of intergenotypic chimeric replicons to determine the broad-spectrum antiviral activities of hepatitis C virus polymerase inhibitors
    Herlihy, Koleen J.
    Graham, Joanne P.
    Kumpf, Robert
    Patick, Amy K.
    Duggal, Rohit
    Shi, Stephanie T.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (10) : 3523 - 3531
  • [3] Development of hepatitis C virus chimeric replicons for identifying broad spectrum NS3 protease inhibitors
    Binder, Joseph
    Tetangco, Selwyna
    Weinshank, Megan
    Maegley, Karen
    Lingardo, Laura
    Diehl, Wade
    Love, Robert
    Patick, Amy K.
    Smith, George J., III
    ANTIVIRAL RESEARCH, 2011, 91 (02) : 102 - 111
  • [4] Development of hepatitis C virus (HCV) chimeric replicons for identifying broad spectrum NS3 protease inhibitors
    Binder, Joseph
    Tetangco, Selwyna
    Wick, Megan
    Maegley, Karen
    Lingardo, Laura
    Patick, Amy
    Smith, George
    ANTIVIRAL RESEARCH, 2007, 74 (03) : A38 - A38
  • [5] Development of a broad-spectrum antiviral with activity against Ebola virus
    Aman, M. Javad
    Kinch, Michael S.
    Warfield, Kelly
    Warren, Travis
    Yunus, Abdul
    Enterlein, Sven
    Stavale, Eric
    Wang, Peifang
    Chang, Shaojing
    Tang, Qingsong
    Porter, Kevin
    Goldblatt, Michael
    Bavari, Sina
    ANTIVIRAL RESEARCH, 2009, 83 (03) : 245 - 251
  • [6] Biochemical mechanism of hepatitis C virus inhibition by the broad-spectrum antiviral arbidol
    Pecheur, Eve-Isabelle
    Lavillette, Dimitri
    Alcaras, Fanny
    Molle, Jennifer
    Boriskin, Yury S.
    Roberts, Michael
    Cosset, Francois-Loic
    Polyak, Stephen J.
    BIOCHEMISTRY, 2007, 46 (20) : 6050 - 6059
  • [7] Soraphen A: A broad-spectrum antiviral natural product with potent anti-hepatitis C virus activity
    Koutsoudakis, George
    Romero-Brey, Ines
    Berger, Carola
    Perez-Vilaro, Gemma
    Perin, Paula Monteiro
    Vondran, Florian Wolfgang Rudolf
    Kalesse, Markus
    Harmrolfs, Kirsten
    Mueller, Rolf
    Martinez, Javier P.
    Pietschmann, Thomas
    Bartenschlager, Ralf
    Broenstrup, Mark
    Meyerhans, Andreas
    Diez, Juana
    JOURNAL OF HEPATOLOGY, 2015, 63 (04) : 813 - 821
  • [8] A screen for novel hepatitis C virus RdRp inhibitor identifies a broad-spectrum antiviral compound
    Abhilasha Madhvi
    Smita Hingane
    Rajpal Srivastav
    Nishant Joshi
    Chandru Subramani
    Rajagopalan Muthumohan
    Renu Khasa
    Shweta Varshney
    Manjula Kalia
    Sudhanshu Vrati
    Milan Surjit
    C. T. Ranjith-Kumar
    Scientific Reports, 7
  • [9] A screen for novel hepatitis C virus RdRp inhibitor identifies a broad-spectrum antiviral compound
    Madhvi, Abhilasha
    Hingane, Smita
    Srivastav, Rajpal
    Joshi, Nishant
    Subramani, Chandru
    Muthumohan, Rajagopalan
    Khasa, Renu
    Varshney, Shweta
    Kalia, Manjula
    Vrati, Sudhanshu
    Surjit, Milan
    Ranjith-Kumar, C. T.
    SCIENTIFIC REPORTS, 2017, 7
  • [10] Initial binding of the broad spectrum antiviral nucleoside ribavirin to the hepatitis C virus RNA polymerase
    Bougie, I
    Bisaillon, M
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (52) : 52471 - 52478
12345